Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea
· Delayed Price · Currency is KRW 4,700.00
+70.00 (1.51%)
At close: Mar 6, 2026
Jin Yang Pharmaceutical Revenue
Jin Yang Pharmaceutical had revenue of 29.25B KRW in the quarter ending September 30, 2025, a decrease of -7.50%. This brings the company's revenue in the last twelve months to 117.19B, up 5.81% year-over-year. In the year 2024, Jin Yang Pharmaceutical had annual revenue of 113.33B with 20.94% growth.
Revenue (ttm)
117.19B
Revenue Growth
+5.81%
P/S Ratio
0.50
Revenue / Employee
532.66M
Employees
220
Market Cap
58.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 113.33B | 19.62B | 20.94% |
| Dec 31, 2023 | 93.71B | 17.44B | 22.87% |
| Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
| Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
| Dec 31, 2020 | 49.52B | 2.17B | 4.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RP Bio | 134.21B |
| Cosmax Nbt | 293.75B |
| Sinil Pharmaceutical | 80.97B |
| Korea Arlico Pharm | 205.21B |
| Kyung Nam Pharm | 56.18B |
| Eagle Veterinary Technology Co.,Ltd | 42.51B |
| Optipharm.CO.,LTD | 21.98B |
| BL Pharmtech | 6.98B |